David Michael Johnson Aura Biosciences, Inc. (AURA) insider trading activity

David Michael Johnson is of Aura Biosciences, Inc.. Currently has a direct ownership of 166,167 shares of AURA, which is worth approximately $1.01 Million. The most recent transaction as insider was on May 16, 2025, when has been sold 20,000 shares (Common Stock) at a price of $4.9 per share, resulting in proceeds of $98,000. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 166K

13.68% 3M change

22.48% 12M change

Total Value Held $1.01 Million

David Michael Johnson Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
May 16 2025	BUY Open market or private purchase	$98,000 $4.9 p/Share	20,000 Added 10.74%	166,167 Common Stock
Jun 20 2024	BUY Grant, award, or other acquisition	-	10,500 Added 6.7%	146,167 Common Stock
Nov 08 2023	BUY Open market or private purchase	$70,087 $7.3 p/Share	9,601 Added 6.61%	135,667 Common Stock
Nov 07 2023	BUY Open market or private purchase	$544,920 $7.17 p/Share	76,000 Added 37.61%	126,066 Common Stock
Oct 04 2023	BUY Open market or private purchase	$56,533 $8.61 p/Share	6,566 Added 11.59%	50,066 Common Stock
Oct 03 2023	BUY Open market or private purchase	$111,645 $8.27 p/Share	13,500 Added 23.68%	43,500 Common Stock
Jun 13 2022	BUY Open market or private purchase	$279,800 $13.99 p/Share	20,000 Added 40.0%	30,000 Common Stock
Jun 10 2022	BUY Open market or private purchase	$150,400 $15.04 p/Share	10,000 Added 50.0%	10,000 Common Stock

Also insider at

ZNTL

Zentalis Pharmaceuticals, Inc. Healthcare

Director

DMJ